Clinical Trial Update: Efficacy and Safety of Rifasutenizol (TNP 2198), Rabeprazole and Amoxicillin in Participants With H. Pylori Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating rifasutenizol (TNP 2198) in combination with rabeprazole and amoxicillin for Helicobacter pylori infection has completed, and efficacy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• Rabeprazole (rabeprazole)
• Rifasutenizol (TNP 2198) (rifasutenizol)

Snippet

Sponsor: TenNor Therapeutics (Suzhou) Limited | Conditions: H.Pylori Infection | Phase 3 | Status: COMPLETED | Results posted: 2025-08-17